Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011811 · ClinicalTrials.gov registry record
Cluster Headache Treatment Survey
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 2,487
- Enrollment target
NCT06011811: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT06011811 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 2,487 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06011811 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 2,487 participants
- Enrollment target
Study Summary
The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,487 participants |
| Start Date | 2023-06-29 |
| Est. Completion | 2025-06-28 |
What the finished NCT06011811 record still lists
NCT06011811 is an observational study that tracks outcomes without assigning an intervention. Its 2,487 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT06011811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06011811 about?
NCT06011811 is a clinical study titled "Cluster Headache Treatment Survey". The objective of this study is to survey patients with cluster headache about treatment effectiveness and their views on treatments. Participants will complete one brief questionnaire online.
What is the current status of trial NCT06011811?
This trial is currently completed. The enrollment target is 2,487 participants. The study started on 2023-06-29. Estimated completion is 2025-06-28.
Who is sponsoring clinical trial NCT06011811?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI